Literature DB >> 7891155

Cerebellar toxicity of phencyclidine.

R Näkki1, J Koistinaho, F R Sharp, S M Sagar.   

Abstract

Phencyclidine (PCP), dizocilpine maleate (MK801), and other NMDA antagonists are toxic to neurons in the posterior cingulate and retrosplenial cortex. To determine if additional neurons are damaged, the distribution of microglial activation and 70 kDa heat shock protein (HSP70) induction was studied following the administration of PCP and MK801 to rats. PCP (10-50 mg/kg) induced microglial activation and neuronal HSP70 mRNA and protein expression in the posterior cingulate and retrosplenial cortex. In addition, coronal sections of the cerebellar vermis of PCP (50 mg/kg) treated rats contained vertical stripes of activated microglial in the molecular layer. In the sagittal plane, the microglial activation occurred in irregularly shaped patches, suggesting damage to Purkinje cells. In accord with this finding, PCP induced HSP70 protein and mRNA expression in Purkinje cells. Although there were relatively few foci of microglial activation and cells with HSP70 protein induction, HSP70 mRNA was detected in many Purkinje cells located throughout the cerebellar hemispheres as well as the vermis. MK801, at doses of 5-10 mg/kg, induced microglial activation and neuronal HSP70 mRNA and protein expression in the cingulate and retrosplenial cortex but not in the cerebellum. At the dose of 1 mg/kg MK801 induced HSP70 but did not consistently activate microglia. These data suggest that microglia are activated by MK801 doses that kill or severely damage neurons, whereas HSP70 is induced in "stressed" neurons at MK801 doses well below those that produce severe neurotoxicity. These observations suggest that PCP, but not MK801, is toxic to Purkinje cells and raise the question of whether NMDA antagonists or sigma ligands other than PCP are toxic to the cerebellum. Moreover, this study illustrates the usefulness of microglial activation and HSP70 induction as markers of neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7891155      PMCID: PMC6578142     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  10 in total

1.  Expression profiling to understand actions of NMDA/glutamate receptor antagonists in rat brain.

Authors:  Petri Törönen; Marcus Storvik; Anni-Maija Lindén; Outi Kontkane; Markéta Marvanová; Merja Lakso; Eero Castrén; Garry Wong
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Bergmann Glia are Patterned into Topographic Molecular Zones in the Developing and Adult Mouse Cerebellum.

Authors:  Stacey L Reeber; Marife Arancillo; Roy V Sillitoe
Journal:  Cerebellum       Date:  2018-08       Impact factor: 3.847

3.  The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia.

Authors:  L Canever; C S V Alves; G Mastella; L Damázio; J V Polla; S Citadin; L A De Luca; A S Barcellos; M L Garcez; J Quevedo; J Budni; A I Zugno
Journal:  Mol Neurobiol       Date:  2017-03-24       Impact factor: 5.590

4.  Spatiotemporal analysis of purkinje cell degeneration relative to parasagittal expression domains in a model of neonatal viral infection.

Authors:  Brent L Williams; Kavitha Yaddanapudi; Mady Hornig; W Ian Lipkin
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

5.  Modified climbing fiber/Purkinje cell synaptic connectivity in the cerebellum of the neonatal phencyclidine model of schizophrenia.

Authors:  Maxime Veleanu; Beetsi Urrieta-Chávez; Séverine M Sigoillot; Maëla A Paul; Alessia Usardi; Keerthana Iyer; Marine Delagrange; Joseph P Doyle; Nathaniel Heintz; Carine Bécamel; Fekrije Selimi
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-19       Impact factor: 12.779

6.  The alkylating agent penclomedine induces degeneration of purkinje cells in the rat cerebellum.

Authors:  Seamus O'Reilly; Elizabeth O'Hearn; Robert F Struck; Eric K Rowinsky; Mark E Molliver
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

7.  Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Authors:  Takahiro Iizuka; Juntaro Kaneko; Naomi Tominaga; Hidehiro Someko; Masaaki Nakamura; Daisuke Ishima; Eiji Kitamura; Ray Masuda; Eiichi Oguni; Toshiyuki Yanagisawa; Naomi Kanazawa; Josep Dalmau; Kazutoshi Nishiyama
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

8.  Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.

Authors:  Samuel A Barnes; Stephen J Sawiak; Daniele Caprioli; Bianca Jupp; Guido Buonincontri; Adam C Mar; Michael K Harte; Paul C Fletcher; Trevor W Robbins; Jo C Neill; Jeffrey W Dalley
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

9.  Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11.

Authors:  Delphine Vandame; Lauriane Ulmann; Marisa Teigell; Monica Prieto-Cappellini; Jacques Vignon; Alain Privat; Regino Perez-Polo; Olivera Nesic; Helene Hirbec
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

Review 10.  Profile of minocycline and its potential in the treatment of schizophrenia.

Authors:  Lulu Zhang; Jingping Zhao
Journal:  Neuropsychiatr Dis Treat       Date:  2014-06-17       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.